arrow
H

Hanna A. Knaus

Medical University of Vienna
H指数:12
被引数:778

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia
2022-11-0143
OAAI
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria

异基因造血干细胞移植前抗胸腺细胞球蛋白/抗T淋巴细胞球蛋白血清疗法预防移植物抗宿主病期间的细胞因子释放综合征: 根据美国移植和细胞治疗学会分级标准的发病率和早期临床影响

2022-05-014
OAAI
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
2021-09-1053
OA
Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation
2020-10-226
OAAI
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS
LEUKEMIA
IF13.4
2020-01-0318
OAAI
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
2018-07-3180
OAAI